glutathione drug release responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics | Discover Oncology PDF) Glutathione-Triggered Drug Release From

10.3389/fmolb.2022.835976 45 FengY.EganB.WangJ

doi: 10.1126/science.1171242

ROS dysregulation in neurodegenerative diseases ROS dysregulation serves as a central pathological mechanism driving neuronal degeneration in multiple major neurodegenerative disorders [330]

Enhance Mood and Reduce Symptoms of Depression Vitamin B12 is integral in the production and metabolism of serotonin, a neurotransmitter significantly influencing mood

"These statements have not been evaluated by the Food and Drug Administration

Her research was funded by independent grants to her from the Medical Research Council of Canada, the National Cancer Institute of Canada and the National Institutes of Health in the United States